Current role
Biotechnology · Healthcare
Board Member
2023-02-03–present
Barbara Duncan
Board Member
Halozyme Therapeutics, Inc. (HALO)Equibles does not estimate personal net worth.
Get an email with a short summary when Halozyme Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get HALO alertsAbout Barbara Duncan
Barbara Duncan is recorded as Board Member at Halozyme Therapeutics, Inc. (HALO) since February 3, 2023. Halozyme Therapeutics, Inc. reported in an 8-K filed February 6, 2023 that Barbara Duncan was appointed Board of Directors, effective February 3, 2023. Halozyme Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Halozyme Therapeutics, Inc. includes Helen Torley (CEO and Board Member), Darren Snellgrove (CFO), Elaine D. Sun (CFO) and 7 others.
“On February 3, 2023, Barbara Duncan was elected to the Board of Directors of Halozyme Therapeutics, Inc. (the “Company”).”
Affiliation history
-
Current
2023-02-03–present
Company network
Leadership on record at Halozyme Therapeutics, Inc.
- Helen Torley CEO, Board Member
- Darren Snellgrove CFO
- Elaine D. Sun CFO
- Nicole LaBrosse CFO
- Cortney Caudill COO
- Mark Snyder General Counsel
- Bernadette Connaughton Board Member
- Connie L. Matsui Board Member
- Dannielle Appelhans Board Member
- James Daly Board Member